AMPK also has a major role in pathological conditions (e.g. metabolic syndrome, cancer, Alzheimer's disease) and therapeutic activation of AMPK is believed to have beneficial advantages for several disease processes. This evidence concerns the gene PRKAA2 and early-onset autosomal dominant Alzheimer disease.